News |  Contact |  Sitemap |  Disclaimer | 
About us  |   Services  |   Territories  |   Partners  |  
Ukraine is the second largest pharmaceutical market in the Commonwealth of Independent States (CIS). Per capita health expenditure is low, even at East European standards. This is due to the fact that almost all funding is out-of-pocket, relying on the abilities of patients to pay for health treatment and drug purchases. Though the introduction of a system of public health insurance has been under discussion for several years, currently there is no insurance coverage or drug reimbursement in place. The market is strongly import- driven and is expected to continue growing on a steady pace as older and less effective medicines are being substituted by branded generics and imported innovative medicines. The increase in average price per pack and the high tendency for self-medication among the general public further fuel market growth and present favourable conditions for companies, which are willing to expand their operations to Ukraine. 


Key facts and figures:


Area:   604'000 km2  
Capital:   Kiev  
Population:   45,20 million (2015)  
Currency:   Ukrainian Grivna (UAH)  
Volume of pharmaceutical market:   USD 2'566'734'320     
Of which imported drugs:   71%  
No. of hospitals:   2'779  
No. of physicians:   202'736  
No. of pharmacies:   19'000  
Our subsidiary:   Ewopharma AG  
    Representation Office  
    c/o OMP LLC  
    9, Tarasovskaya Street  
    UA - 01033 Kiev  
    Office: +38 044 391 3001  
    Fax:    +38 044 391 3002  
Administration 0
Sales and Marketing 0